Use of Ultrasound, CT, CTE, and MRE to Predict the Severity of Crohn's Disease Compared
By MedImaging International staff writers Posted on 23 Mar 2015 |
Researchers have reported on the results of a study investigating the effectiveness of ultrasound, for patients with Crohn's disease.
Scientists at the University of Calgary (Calgary, AB, Canada) assessed the equivalence of transabdominal ultrasound, temporally related Computed Tomography (CT), Computed Tomography Enterography (CTE), and Magnetic Resonance Enterography (MRE) for predicting disease activity and intestinal complications in patients with Crohn's disease.
The researchers made a retrospective analysis of 308 consecutive patients suffering from Crohn's disease, all of whom had ultrasound, CT, CTE, and MRE scans, without any intervening therapy. The scans were independently reviewed and graded by specialty-physicians for overall disease activity, bowel wall thickening, presence of inflammatory fat, and mural blood flow, with the intent to identify and report complications.
The results showed disease activity grades on ultrasound and reference imaging were concordant in 98.05% of patients on the basis of wall thickness, 87.13% with respect to inflammatory fat, and 96.69% on the basis of blood flow.
The researchers concluded that the use of transabdominal ultrasound was equivalent to, and even superior in some cases, to either CT or CTE/MRE in predicting disease activity and clinical complications in Crohn's disease. The researchers also concluded that ultrasound could be used effectively as a first line investigation tool for emergency and routine surveillance of the disease.
The researchers reported their findings at the 2015 European Congress of Radiology (ECR) in Vienna (Austria).
Related Links:
University of Calgary
Scientists at the University of Calgary (Calgary, AB, Canada) assessed the equivalence of transabdominal ultrasound, temporally related Computed Tomography (CT), Computed Tomography Enterography (CTE), and Magnetic Resonance Enterography (MRE) for predicting disease activity and intestinal complications in patients with Crohn's disease.
The researchers made a retrospective analysis of 308 consecutive patients suffering from Crohn's disease, all of whom had ultrasound, CT, CTE, and MRE scans, without any intervening therapy. The scans were independently reviewed and graded by specialty-physicians for overall disease activity, bowel wall thickening, presence of inflammatory fat, and mural blood flow, with the intent to identify and report complications.
The results showed disease activity grades on ultrasound and reference imaging were concordant in 98.05% of patients on the basis of wall thickness, 87.13% with respect to inflammatory fat, and 96.69% on the basis of blood flow.
The researchers concluded that the use of transabdominal ultrasound was equivalent to, and even superior in some cases, to either CT or CTE/MRE in predicting disease activity and clinical complications in Crohn's disease. The researchers also concluded that ultrasound could be used effectively as a first line investigation tool for emergency and routine surveillance of the disease.
The researchers reported their findings at the 2015 European Congress of Radiology (ECR) in Vienna (Austria).
Related Links:
University of Calgary
Latest MRI News
- Low-Cost Whole-Body MRI Device Combined with AI Generates High-Quality Results
- World's First Whole-Body Ultra-High Field MRI Officially Comes To Market
- World's First Sensor Detects Errors in MRI Scans Using Laser Light and Gas
- Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans
- Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients
- PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients
- Next Generation MR-Guided Focused Ultrasound Ushers In Future of Incisionless Neurosurgery
- Two-Part MRI Scan Detects Prostate Cancer More Quickly without Compromising Diagnostic Quality
- World’s Most Powerful MRI Machine Images Living Brain with Unrivaled Clarity
- New Whole-Body Imaging Technology Makes It Possible to View Inflammation on MRI Scan
- Combining Prostate MRI with Blood Test Can Avoid Unnecessary Prostate Biopsies
- New Treatment Combines MRI and Ultrasound to Control Prostate Cancer without Serious Side Effects
- MRI Improves Diagnosis and Treatment of Prostate Cancer
- Combined PET-MRI Scan Improves Treatment for Early Breast Cancer Patients
- 4D MRI Could Improve Clinical Assessment of Heart Blood Flow Abnormalities
- MRI-Guided Focused Ultrasound Therapy Shows Promise in Treating Prostate Cancer